Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4776-2 (miR-4776-2) is a small non-coding RNA molecule belonging to the microRNA family. It primarily functions in post-transcriptional gene silencing by incorporating into the RNA-induced silencing complex (RISC) and guiding it to partially complementary sequences in target mRNAs, resulting in translational repression or mRNA degradation[1][2][4]. One demonstrated functional role is the downregulation of NFKBIB, a regulator of NF-κB, implicating miR-4776-2 in the control of cell proliferation, apoptosis, and cell survival, and highlighting a potential regulatory role in infectious and inflammatory processes (e.g., during influenza infection)[4]. There is no evidence that miR-4776-2 itself is a therapeutic target (such as a receptor, enzyme, transporter, or similar druggable protein), and there are no approved drugs that directly target this microRNA[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4776-2 (miR-4776-2).